Follow
Robert F Gagel
Robert F Gagel
Professor of Medicine, M.D. Anderson Cancer Center
Verified email at mdanderson.org - Homepage
Title
Cited by
Cited by
Year
Consensus: guidelines for diagnosis and therapy of MEN type 1 and type 2
ML Brandi, RF Gagel, A Angeli, JP Bilezikian, P Beck-Peccoz, C Bordi, ...
The Journal of clinical endocrinology & metabolism 86 (12), 5658-5671, 2001
25492001
Bisphosphonate‐associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research
S Khosla, D Burr, J Cauley, DW Dempster, PR Ebeling, D Felsenberg, ...
Journal of bone and mineral research 22 (10), 1479-1491, 2007
19322007
Medullary thyroid cancer: management guidelines of the American Thyroid Association
RT Kloos, C Eng, DB Evans, GL Francis, RF Gagel, H Gharib, JF Moley, ...
Thyroid 19 (6), 565-612, 2009
16582009
Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial
SA Wells Jr, BG Robinson, RF Gagel, H Dralle, JA Fagin, M Santoro, ...
Journal of clinical oncology 30 (2), 134, 2012
16042012
The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2: International RET Mutation Consortium analysis
C Eng, D Clayton, I Schuffenecker, G Lenoir, G Cote, RF Gagel, ...
Jama 276 (19), 1575-1579, 1996
14321996
Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy
PM Thomas, GJ Cote, N Wohllk, B Haddad, PM Mathew, W Rabl, ...
Science 268 (5209), 426-429, 1995
10101995
Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates
AO Hoff, BB Toth, K Altundag, MM Johnson, CL Warneke, M Hu, A Nooka, ...
Journal of Bone and Mineral Research 23 (6), 826-836, 2008
8282008
Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer
R Kurzrock, SI Sherman, DW Ball, AA Forastiere, RB Cohen, R Mehra, ...
Journal of Clinical Oncology 29 (19), 2660, 2011
6142011
Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease
H Neumann, DP Berger, G Sigmund, U Blum, D Schmidt, RJ Parmer, ...
New England Journal of Medicine 329 (21), 1531-1538, 1993
5951993
Vandetanib for the treatment of patients with locally advanced or metastatic hereditary medullary thyroid cancer
SA Wells Jr, JE Gosnell, RF Gagel, J Moley, D Pfister, JA Sosa, M Skinner, ...
Journal of Clinical Oncology 28 (5), 767, 2010
5942010
Adrenal cortical carcinoma
APB Dackiw, JE Lee, RF Gagel, DB Evans
World journal of surgery 25 (7), 914-926, 2001
4182001
The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a
RF Gagel, AH Tashjian Jr, T Cummings, N Papathanasopoulos, ...
New England Journal of Medicine 318 (8), 478-484, 1988
4181988
American Thyroid Association guidelines task force on medullary thyroid carcinoma. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma
SA Wells Jr, SL Asa, H Dralle, R Elisei, DB Evans, RF Gagel, N Lee, ...
Thyroid 25 (6), 567-610, 2015
4162015
RET Proto-Oncogene: A Review and Update of Genotype–Phenotype Correlations in Hereditary Medullary Thyroid Cancer and Associated Endocrine Tumors
MA Kouvaraki, SE Shapiro, ND Perrier, GJ Cote, RF Gagel, AO Hoff, ...
Thyroid 15 (6), 531-544, 2005
3542005
Parathyroid carcinoma: a 22‐year experience
NL Busaidy, C Jimenez, MA Habra, PN Schultz, AK El‐Naggar, ...
Head & Neck: Journal for the Sciences and Specialties of the Head and Neck …, 2004
3412004
Genotype‐phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium
LM Mulligan, DJ Marsh, BG Robinson, I Schuffenecker, J Zedenius, ...
Journal of internal medicine 238 (4), 343-346, 1995
3371995
American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules
H Gharib, E Papini, R Valcavi, HJ Baskin, A Crescenzi, ME Dottorini, ...
Endocrine Practice 12 (1), 63-102, 2006
3362006
Safety and efficacy of long-term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients--a clinical research center study
CB Newman, S Melmed, PJ Snyder, WF Young, LD Boyajy, R Levy, ...
The Journal of Clinical Endocrinology & Metabolism 80 (9), 2768-2775, 1995
3321995
ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes
JG Guillem, WC Wood, JF Moley, A Berchuck, BY Karlan, DG Mutch, ...
Annals of surgical oncology 13, 1296-1321, 2006
3232006
Octreotide as primary therapy for acromegaly
CB Newman, S Melmed, A George, D Torigian, M Duhaney, P Snyder, ...
The Journal of Clinical Endocrinology & Metabolism 83 (9), 3034-3040, 1998
3131998
The system can't perform the operation now. Try again later.
Articles 1–20